Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade Date (v2020B1)

Specifications Manual for Joint Commission National Quality Measures (v2020B1)

Posted: 3/30/2020

Print this page

Home » Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade Date

Release Notes:
Data Element
Version 2020B1

Name:

Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade Date

Collected For:

CSTK-11, CSTK-12

Definition:

The month, date, and year that a Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade of 2B/3 was first documented during the mechanical thrombectomy procedure.

Question:

What was the date that a TICI 2B/3 was first documented during the mechanical thrombectomy procedure?

Format:

Length:	10 - MM-DD-YYYY (includes dashes) or UTD
Type:	Date
Occurs:	1

Allowable Values:

MM = Month (01-12)
DD = Day (01-31)
YYYY = Year (2001-Current Year)
UTD = Unable to Determine

Notes for Abstraction:

Use the date a TICI 2B/3 was first documented. If a discrepancy exists in date documentation from different sources, choose the earliest date. If multiple dates are documented during the procedure, use the earliest date.
The procedure end date may be used if an earlier date is not documented during the procedure.
If the date a TICI 2B/3 was first documented is unable to be determined from medical record documentation, select “UTD”.
The medical record must be abstracted as documented (taken at “face value”). When the date documented is obviously in error (not a valid date/format) and no other documentation is found that provides this information, the abstractor should select “UTD”.
Example:
Documentation indicates the Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade Date was 03-*42*-20xx. No other documentation in the medical record provides a valid date. Since the Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade Date is outside of the range listed in the Allowable Values for “Day,” it is not a valid date and the abstractor should select “UTD”.
Note:
Transmission of a case with an invalid date as described above will be rejected from the Joint Commission’s Data Warehouse. Use of “UTD” for Post-Treatment Thrombolysis in Cerebral Infarction (TICI) Reperfusion Grade Date allows the case to be accepted into the warehouse.

Suggested Data Sources:

Consultation notes
Progress notes
Operative report
Procedure notes

Additional Notes:

Guidelines for Abstraction:

Inclusion	Exclusion
None	None

Specifications Manual for Joint Commission National Quality Measures (v2020B1)
Discharges 07-01-20 (3Q20) through 12-31-20 (4Q20)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.